Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization Sort ascending
Oct
18
2019
McDermottPlus Check-Up: October 18, 2019 McDermott Will & Emery
Mar
13
2024
This Week in 340B: March 5 – 12, 2024 McDermott Will & Emery
Mar
15
2024
Florida Bills Intended to Curtail Physician Noncompetes Fail McDermott Will & Emery
Oct
31
2019
Podcast | Culture Clashes: Getting Cross-Industry Collaborations Right McDermott Will & Emery
Apr
18
2017
How to Use the New OIG-HCCA Compliance Resource Guide in Your Compliance Program McDermott Will & Emery
Apr
15
2024
Healthcare Preview for the Week of: April 15, 2024 [Podcast] McDermott Will & Emery
Dec
12
2019
New Podcast: Whose Data Is It Anyway? Collaboration in Digital Health McDermott Will & Emery
Apr
17
2024
Hospital Settles With OCR for $4.75 Million Over HIPAA Violations McDermott Will & Emery
Dec
20
2019
McDermott Plus Check-Up: December 20, 2019 McDermott Will & Emery
May
30
2014
What Is “a Patient?” McDermott Will & Emery
Feb
5
2020
CMS Updates QPP Resources McDermott Will & Emery
Mar
10
2022
Lawyers Scolded but Not Sanctioned for Violating Federal Circuit’s COVID-19 Rules McDermott Will & Emery
Jun
4
2014
Federal Trade Commission's (FTC) Reporting Rule for Pharmaceutical Patent Transfers Upheld McDermott Will & Emery
Mar
25
2022
In the Trenches, Ep. 13: Part 2 | Are We There Yet? Provider Relief Fund (PRF) Reporting and Enforcement with Epsilon Life Sciences {PODCAST] McDermott Will & Emery
Mar
5
2020
CMS Takes Unprecedented Action To Modify Survey Activities In Response To COVID-19 McDermott Will & Emery
Jul
22
2014
FDA Issues Draft Guidance on Communications Over Internet and Social Media Platforms McDermott Will & Emery
Apr
29
2022
Developments in UK Life Sciences – Spring Update 2022 McDermott Will & Emery
Sep
25
2017
Par Pharmaceutical Beats FCA Prescription-Switch Allegations McDermott Will & Emery
Aug
30
2014
Opinion Underlying Judgment as a Matter of Law (JMOL) May Still Provide Basis for a New Trial, Even if JMOL Is Defective McDermott Will & Emery
Mar
19
2020
COVID-19 Telehealth Guidance: What You Need to Know McDermott Will & Emery
Mar
23
2020
Executive And Physician Compensation, Benefits And Contract Issues In The COVID-19 Era McDermott Will & Emery
Oct
2
2014
Patent and Trademark Office (PTO) Decision Not to Institute IPR Is Final and Not Appealable McDermott Will & Emery
Jun
24
2022
McDermottPlus Check-Up: June 24, 2022 McDermott Will & Emery
Aug
12
2022
Navigating Volatile Markets in the Digital Health Ecosystem | Introduction – What to Consider [Podcast] McDermott Will & Emery
Aug
29
2022
Key Takeaways | In the Room Where It Happened McDermott Will & Emery
Apr
28
2020
OIG Penalties Expand to Grant and Contract Fraud McDermott Will & Emery
Apr
29
2020
Bill Extends Medicare Telehealth Coverage for Therapy Providers McDermott Will & Emery
May
3
2020
CMS Updates COVID-19 Guidance for MA Organizations and Part D Sponsors, Addresses the Status of Telehealth Visits for Risk Adjustment McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins